[go: up one dir, main page]

WO1990004967A3 - Pommade topique - Google Patents

Pommade topique Download PDF

Info

Publication number
WO1990004967A3
WO1990004967A3 PCT/EP1989/001276 EP8901276W WO9004967A3 WO 1990004967 A3 WO1990004967 A3 WO 1990004967A3 EP 8901276 W EP8901276 W EP 8901276W WO 9004967 A3 WO9004967 A3 WO 9004967A3
Authority
WO
WIPO (PCT)
Prior art keywords
ointment
oil
topical ointment
spermaceti
efficacity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP1989/001276
Other languages
German (de)
English (en)
Other versions
WO1990004967A2 (fr
Inventor
Gabriele Flender
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP1511363A priority Critical patent/JPH0647544B2/ja
Publication of WO1990004967A2 publication Critical patent/WO1990004967A2/fr
Publication of WO1990004967A3 publication Critical patent/WO1990004967A3/fr
Priority to DK007191A priority patent/DK7191A/da
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

Une pommade topique pour le traitement localisé de dermatoses, en particulier du psoriasis, contient entre 10 et 50 % en poids de vaseline, entre 10 et 50 % en poids d'huile de jujube, entre 1 et 10 % en poids de cholestérine, entre 1 et 10 % en poids de cire d'abeille ou de cétine ou de succédané de cétine, et enfin entre 10 et 40 % en poids d'eau. L'efficacité remarquable de cette pommmade est due avant tout aux vertus pharmaceutiques de la cholestérine qui entre dans sa composition. Ladite pommade est en outre particulièrement bien supportée par les peaux sensibles et à tendance allergique.
PCT/EP1989/001276 1988-10-31 1989-10-26 Pommade topique Ceased WO1990004967A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP1511363A JPH0647544B2 (ja) 1988-10-31 1989-10-26 乾癬の局所治療薬
DK007191A DK7191A (da) 1988-10-31 1991-01-15 Topisk salve

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP3836971.0 1988-10-31
DE3836971A DE3836971C1 (fr) 1988-10-31 1988-10-31

Publications (2)

Publication Number Publication Date
WO1990004967A2 WO1990004967A2 (fr) 1990-05-17
WO1990004967A3 true WO1990004967A3 (fr) 1990-06-28

Family

ID=6366210

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1989/001276 Ceased WO1990004967A2 (fr) 1988-10-31 1989-10-26 Pommade topique

Country Status (11)

Country Link
US (1) US5179086A (fr)
EP (2) EP0367103B1 (fr)
JP (1) JPH0647544B2 (fr)
AT (1) ATE84216T1 (fr)
CA (1) CA2001797A1 (fr)
DE (2) DE3836971C1 (fr)
DK (1) DK7191A (fr)
ES (1) ES2053907T3 (fr)
GR (1) GR3007370T3 (fr)
PT (1) PT92148B (fr)
WO (1) WO1990004967A2 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2705030A1 (fr) * 1993-05-11 1994-11-18 Biodev Utilisation de composés stéroliques pour la fabrication d'un médicament anti-inflammatoire.
US5888984A (en) * 1994-05-12 1999-03-30 Dermal Research Laboratories, Inc. Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
US5444092A (en) * 1994-07-20 1995-08-22 Collins; Jerry Method and composition for treating psoriasis
GB9814527D0 (en) * 1998-07-03 1998-09-02 Cyclacel Ltd Delivery system
ES2318906T3 (es) 1998-11-13 2009-05-01 Cyclacel Limited Vectores de transposicion derivados de helice 3 de homeodominio de antennapedia.
CA2361268C (fr) 1999-02-01 2014-06-10 Dermal Research Laboratories, Inc. Composition pharmaceutique d'hydrates de carbone complexes et d'huiles essentielles et methode d'utilisation de celle-ci
US7879824B2 (en) * 2001-07-31 2011-02-01 Dermal Research Laboratories, Inc. Methods of preventing or treating diseases and conditions using complex carbohydrates
TNSN02063A1 (en) * 2001-07-07 2005-12-23 Egyptian Natural Oil Co Natoil The medical effect of jojoba oil
US7048914B2 (en) * 2002-12-12 2006-05-23 Zoltan Laboratories Placental alkaline phosphatase to control diabetes
US20050002884A1 (en) * 2003-07-02 2005-01-06 Marsella Jefferson Hair treatment compositions
US7374754B2 (en) * 2003-09-02 2008-05-20 Essential Skincare, Llc Use of placental alkaline phosphatase to promote skin cell proliferation
US8455016B2 (en) * 2004-03-12 2013-06-04 Melbj Holdings, Llc Treatment for meibomian gland dysfunction or obstruction
US7695714B2 (en) * 2005-12-28 2010-04-13 Zoltan Laboratories Llc Use of alkaline phosphatase to maintain healthy tissue mass in mammals
CA2735968A1 (fr) * 2008-12-24 2010-07-01 Biomedcore Inc. Procede de fabrication d'un liposome et procede de dissolution de cholesterol
WO2011136283A1 (fr) 2010-04-28 2011-11-03 久光製薬株式会社 Suppresseur d'irritation cutanée et préparation transdermique
ES2547888T3 (es) 2010-04-28 2015-10-09 Hisamitsu Pharmaceutical Co., Inc. Preparación que contiene donepezilo absorbible por vía transdérmica
EP2772252B1 (fr) 2011-10-26 2020-03-18 Hisamitsu Pharmaceutical Co., Inc. Préparation à absorption transdermique comprenant une oxybutynine
US9717741B2 (en) 2012-10-11 2017-08-01 Anaplasi Pharmaceuticals Llc Method and compositions for treating psoriasis
US9987361B1 (en) 2014-12-29 2018-06-05 Noven Pharmaceuticals, Inc. Compositions and method for sustained drug delivery by active transdermal technology
GB201814036D0 (en) 2018-08-29 2018-10-10 Ucl Business Plc New therapy
US20210393724A1 (en) * 2018-11-01 2021-12-23 Yeditepe Universitesi Medicine for treatment of psoriasis and production method thereof
GB201918752D0 (en) * 2019-12-18 2020-01-29 Ucl Business Plc New therapy

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0098568A2 (fr) * 1982-07-07 1984-01-18 Schering Aktiengesellschaft Préparations pour l'application topique contenant des corticoides
DE3526669A1 (de) * 1984-07-26 1986-02-06 Oreal Neues emulsionssystem auf basis eines erdalkali- oder metallischen lanolates und emulsionen des wasser-in-oel-typs auf basis dieses emulsionssystems

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE523144C (de) * 1927-09-11 1931-04-20 Friedrich Passek Verfahren zur Herstellung wasserreicher Cholesterinloesungen
DE638839C (de) * 1935-01-15 1936-11-24 Chem Fab Promonta G M B H Verfahren zur Herstellung waessrig-alkoholischer Cholesterinloesungen
FR928337A (fr) * 1946-05-20 1947-11-25 Procédé d'obtention de solutions stables de cholestérine, en vue de la préparation de produits cosmétiques et de beauté
FR2485921A1 (fr) * 1980-07-01 1982-01-08 Oreal Composition cosmetique a base d'une dispersion aqueuse de spherules lipidiques
IT8221553A0 (it) * 1982-05-28 1982-05-28 Gruppo Scient Revici Pacelli Composizioni farmaceutiche adattivita' antineoplastica.
US4743597A (en) * 1986-01-27 1988-05-10 Javitt Norman B Composition comprising an oxygenated cholesterol and use thereof for topical treatment of diseases
FR2597346B1 (fr) * 1986-04-22 1989-08-18 Oreal Procede pour faciliter la formation de niosomes en dispersion dans une phase aqueuse et pour ameliorer leur stabilite et leur taux d'encapsulation, et dispersions correspondantes.

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0098568A2 (fr) * 1982-07-07 1984-01-18 Schering Aktiengesellschaft Préparations pour l'application topique contenant des corticoides
DE3526669A1 (de) * 1984-07-26 1986-02-06 Oreal Neues emulsionssystem auf basis eines erdalkali- oder metallischen lanolates und emulsionen des wasser-in-oel-typs auf basis dieses emulsionssystems

Also Published As

Publication number Publication date
WO1990004967A2 (fr) 1990-05-17
ATE84216T1 (de) 1993-01-15
JPH0647544B2 (ja) 1994-06-22
DK7191A (da) 1991-06-04
CA2001797A1 (fr) 1990-04-30
DK7191D0 (da) 1991-01-15
ES2053907T3 (es) 1994-08-01
DE3836971C1 (fr) 1990-05-17
GR3007370T3 (fr) 1993-07-30
EP0367103A1 (fr) 1990-05-09
JPH04501415A (ja) 1992-03-12
EP0440715A1 (fr) 1991-08-14
DE58903222D1 (de) 1993-02-18
PT92148B (pt) 1995-06-30
US5179086A (en) 1993-01-12
EP0367103B1 (fr) 1993-01-07
PT92148A (pt) 1990-05-31

Similar Documents

Publication Publication Date Title
WO1990004967A3 (fr) Pommade topique
US4512978A (en) Dermatological composition useful in the treatment of psoriasis
ATE104845T1 (de) Tocopherolsorbat und entzuendungshemmende wirkstoffe enthaltende lichtschutzmittel.
IE831611L (en) Topical anti-inflammatory compositions
EP0336880A3 (fr) Utilisation de préparations applicables topiquement pour le traitement du vieillissement de la peau
EP0336902A3 (fr) Composition antiinflammatoire humectante et procédé pour sa préparation
AU2408688A (en) Photoprotection compositions comprising sorbohydroxamic acid
BE904421A (fr) Derives heterocycliques aromatiques et leur application dans les domaines therapeutique et cosmetique.
EP0297733A3 (fr) Médicaments contenant des butanes catécholiques
AU598020B2 (en) Cosmetic composition
AU690377B2 (en) Application of superoxide dismutase in liposomes
EP0249736A3 (fr) Onguent pour le traitement des maladies de peau
AU2726692A (en) Penetration enhancement of topically applied formulations
AU674142B2 (en) Use of cosmetic composition
AU7233787A (en) Novel topical metronidazole formulations and therapeutic uses thereof
AU5916990A (en) Preparations for topical use containing depolymerized deoxyribonucleic acids to reduce unsightly defects of the epidermis of the face and some skin areas of the body
SE9801647D0 (sv) Therapeutic composition
EP0754456A3 (fr) Utilisation en application topique de ST1435 en tant qu'agent contraceptif
EP0801945A3 (fr) Utilisation de glucosides de l'acide férilique comme actifs contre l'irritation dans des compositions cosmétiques ou topiques dermatologiques
DE3867560D1 (de) Verwendung von azidothymidin zur behandlung der psoriasis.
EP0249193A3 (fr) Véhicule pour application topique de produits pharmaceutiques
CA2061870A1 (fr) Compositions medicinales utilisees comme cremes hydratantes et dans le traitement de l'eczema
ES8706027A1 (es) Procedimiento de obtencion de una composicion para el tratamiento de vitiligo
DE2729010C2 (de) Arzneimittel zur Behandlung der Cellulite und des Fettübergewichtes
KR880009656A (ko) 국소 치근막 질환의 치료 또는 예방법

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): DK JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE FR GB IT LU NL SE

AK Designated states

Kind code of ref document: A3

Designated state(s): DK JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE FR GB IT LU NL SE

WWE Wipo information: entry into national phase

Ref document number: 1989912240

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1989912240

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1989912240

Country of ref document: EP